Vir Biotechnology
220 hedge funds and large institutions have $1.68B invested in Vir Biotechnology in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 94 increasing their positions, 54 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
8% more call options, than puts
Call options by funds: $5.6M | Put options by funds: $5.17M
0.69% more ownership
Funds ownership: 64.83% → 65.52% (+0.69%)
24% less capital invested
Capital invested by funds: $2.2B → $1.68B (-$524M)
Holders
220
Holding in Top 10
4
Calls
$5.6M
Puts
$5.17M
Top Buyers
| 1 | +$44M | |
| 2 | +$27M | |
| 3 | +$24.2M | |
| 4 |
Temasek Holdings
Singapore
|
+$11M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$10.1M |
Top Sellers
| 1 | -$61.1M | |
| 2 | -$58.6M | |
| 3 | -$19.9M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$19.3M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$11.9M |